+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Biomarker Diagnostic Kits Market - Global Forecast 2026-2032- Product Image
Cardiac Biomarker Diagnostic Kits Market - Global Forecast 2026-2032- Product Image
New

Cardiac Biomarker Diagnostic Kits Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011196
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiac biomarker diagnostic kits market is advancing rapidly, offering healthcare providers efficient tools for timely cardiovascular diagnosis. Senior decision-makers face a complex environment marked by regulatory evolution, emergent care pathways, and ongoing advancements in diagnostic technology.

Market Snapshot: Cardiac Biomarker Diagnostic Kits Market

Between 2025 and 2026, the Cardiac Biomarker Diagnostic Kits Market expanded from USD 3.45 billion to USD 3.69 billion and is forecasted to reach USD 5.71 billion by 2032, reflecting a CAGR of 7.47%. This consistent market growth is driven by the expanding importance of precise and rapid cardiac marker testing, which supports effective clinical decisions across acute care, chronic disease management, and preventive cardiology on a global scale.

Scope & Segmentation

This report provides a comprehensive analysis of the cardiac biomarker diagnostic kits market, offering actionable insights for manufacturers, procurement professionals, and clinical leaders across operational segments and regions.

  • Biomarker Types: Includes B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin, Creatine Kinase-MB, and Myoglobin—each supporting different clinical risk profiles in cardiovascular care.
  • Clinical Indications: Covers angina pectoris, heart failure, myocardial infarction, and other critical cardiovascular disorders, emphasizing the diagnostic impact across varying acuity levels.
  • Testing Modalities: Encompasses both in vitro and in vivo methodologies, with workflows spanning centralized laboratory testing and decentralized point-of-care platforms.
  • Purchasing Behaviors: Addresses acquisition through direct health system procurement, third-party suppliers, and group purchasing organizations to optimize supply chain resilience.
  • Applications: Includes central laboratory diagnostics, bedside point-of-care testing, and research-driven use cases, reflecting broad operational utilization.
  • End Users: Considers hospitals, clinics, diagnostic laboratories, academic institutions, and research entities actively engaged in cardiovascular care delivery.
  • Regions: Analyzes key differences among markets in the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting region-specific dynamics and adoption drivers.
  • Key Technologies: Evaluates advancements such as improved assay sensitivity, multiplexed panel capabilities, miniaturization for portable deployment, and integration with digital health infrastructure.

Key Takeaways for Senior Decision-Makers

  • Continued improvements in assay platforms and an expanding scope for point-of-care diagnostics are increasing both the accuracy and speed of cardiovascular condition detection.
  • Healthcare professionals and purchasing teams now expect solutions that are not only evidence-based and economical but also compatible with existing health IT systems to streamline workflows.
  • Strategically differentiating products for specific clinical uses—such as leveraging ultra-sensitive assays for heart failure and rapid testing platforms for acute cardiac events—helps meet a diverse spectrum of operational requirements.
  • Close collaboration between diagnostic developers, healthcare providers, and payers is facilitating market acceptance as models for co-development and outcome-focused contract management drive momentum.
  • Successfully accessing and expanding in global markets depends on a nuanced understanding of local regulatory standards, infrastructural readiness, and reimbursement criteria, necessitating tailored go-to-market approaches.

Impact of United States 2025 Tariff Measures

The implementation of recent tariff measures in the United States is prompting companies across the cardiac biomarker diagnostic kits supply chain to reassess sourcing and production models. Adjustments to import cost structures are leading manufacturers to increase domestic production, expand supplier networks, and explore new reagent chemistries. Operational agility is achieved through updated contracting strategies, revised inventory management, and enhanced regulatory alignment to support continued product access and consistent patient outcomes. These measures contribute to greater supply chain stability and responsiveness in a changing economic landscape.

Methodology & Data Sources

The insights in this analysis are derived from primary interviews with laboratory managers, cardiologists, procurement leaders, and executives, complemented by secondary research from scientific publications, regulatory updates, and technology studies. Rigorous triangulation and expert review validate findings, ensuring both accuracy and relevance to market realities.

Why This Report Matters

  • Empowers senior decision-makers with focused intelligence on market trends, enabling alignment of product strategies to current and future clinical and procurement demands.
  • Supports informed decision-making by clarifying how regional, regulatory, and supply dynamics impact market access and commercialization plans.
  • Translates technological innovation into actionable recommendations for optimizing performance, ensuring organizational resilience, and enhancing clinical outcomes.

Conclusion

Sustained growth in the cardiac biomarker diagnostic kits market depends on unified efforts across development, validation, and supply management. Senior leaders who prioritize adaptability and collaborate across regulatory and supply chains are best placed to realize long-term value and operational success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cardiac Biomarker Diagnostic Kits Market, by Biomarker Type
8.1. B-Type Natriuretic Peptide
8.2. C-Reactive Protein
8.3. Cardiac Troponin
8.4. Creatine Kinase-MB
8.5. Myoglobin
9. Cardiac Biomarker Diagnostic Kits Market, by Indication
9.1. Angina Pectoris
9.2. Heart Failure
9.3. Myocardial Infarction
10. Cardiac Biomarker Diagnostic Kits Market, by Testing Type
10.1. In Vitro Testing
10.2. In Vivo Testing
11. Cardiac Biomarker Diagnostic Kits Market, by Purchasing Mode
11.1. Direct Purchasing
11.2. Third-Party Suppliers
12. Cardiac Biomarker Diagnostic Kits Market, by Application
12.1. Laboratory Testing
12.1.1. Central Laboratory Testing
12.1.2. Point-of-Care Testing
12.2. Research Applications
13. Cardiac Biomarker Diagnostic Kits Market, by End User
13.1. Academic & Research Institutions
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
14. Cardiac Biomarker Diagnostic Kits Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Cardiac Biomarker Diagnostic Kits Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Cardiac Biomarker Diagnostic Kits Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Cardiac Biomarker Diagnostic Kits Market
18. China Cardiac Biomarker Diagnostic Kits Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Atlas Medical GmbH
19.7. Beckman Coulter, Inc.
19.8. Bio-Rad Laboratories, Inc.
19.9. bioMérieux SA
19.10. Creative Diagnostics
19.11. Eurolyser Diagnostica GmbH
19.12. F. Hoffmann-La Roche Ltd.
19.13. Fujirebio Diagnostics, Inc.
19.14. GenWay Biotech, Inc.
19.15. Guangzhou Wondfo Biotech Co., Ltd.
19.16. J.Mitra & Co. Pvt. Ltd.
19.17. Lepu Medical Technology (Beijing) Co., Ltd.
19.18. Medtronic Inc.
19.19. Meridian Bioscience, Inc.
19.20. MP Biomedicals, LLC
19.21. Radiometer Medical ApS
19.22. Randox Laboratories Ltd.
19.23. Siemens Healthcare GmbH
19.24. Singulex, Inc.
19.25. SSI Diagnostica A/S Group
19.26. Thermo Fisher Scientific, Inc.
19.27. Tosoh Corporation
19.28. Trivitron Healthcare
19.29. Tulip Diagnostics (P) Ltd
List of Figures
FIGURE 1. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC TROPONIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC TROPONIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC TROPONIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CREATINE KINASE-MB, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CREATINE KINASE-MB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CREATINE KINASE-MB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VITRO TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VITRO TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VIVO TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VIVO TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIRECT PURCHASING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIRECT PURCHASING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIRECT PURCHASING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 102. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 106. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 117. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 118. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 119. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 120. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 122. AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 135. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 139. ASEAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 142. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 143. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 144. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 145. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 147. GCC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 158. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 159. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 160. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 161. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 163. BRICS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 166. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 167. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 168. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 169. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 171. G7 CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 174. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 175. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 176. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 177. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 179. NATO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 191. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 192. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 193. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2032 (USD MILLION)
TABLE 194. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2032 (USD MILLION)
TABLE 196. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cardiac Biomarker Diagnostic Kits market report include:
  • Abbott Laboratories
  • Atlas Medical GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Creative Diagnostics
  • Eurolyser Diagnostica GmbH
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Diagnostics, Inc.
  • GenWay Biotech, Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • J.Mitra & Co. Pvt. Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Inc.
  • Meridian Bioscience, Inc.
  • MP Biomedicals, LLC
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens Healthcare GmbH
  • Singulex, Inc.
  • SSI Diagnostica A/S Group
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Trivitron Healthcare
  • Tulip Diagnostics (P) Ltd

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.69 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.71 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Cardiac Biomarkers Market Report 2025 - Product Image

Cardiac Biomarkers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cardiac Biomarkers Testing Market Report 2025 - Product Image

Cardiac Biomarkers Testing Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cardiac Biomarkers Testing Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Cardiac Biomarkers Testing Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Cardiac Biomarkers Market - Types, Applications and Testing Locations - Product Image

Cardiac Biomarkers Market - Types, Applications and Testing Locations

  • Report
  • 256 Pages
  • Global
From
Cardiac Biomarker Market - Global Forecast 2026-2032 - Product Image

Cardiac Biomarker Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From

About the Cardiac Marker Testing Market

The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence. Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events. Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.